Re: Killing Capacity of MMS

[Guest guest]

Hello Healinghope,

WF-10 showed some promise and actually made it through stage 2 clinical trials.

Unfortunately, the final clinical trials have been canceled because it was not

as effective as they were hoping it would be.

Perhaps they will be able to tweak the mix a little and improve their results.

Tom

--- In , " healinghope " <mfrreman@...>

wrote:

>

> Immune Regulation Platform

> Nuvo's second technology - an immune system regulation platform - is based on

WF10, a solution of OXO-K993 containing stabilized chlorite ions.

>

> The immune system provides an essential defence to micro organisms, cancer and

substances it sees as foreign and potentially harmful. The Company's immune

system regulation platform, focuses on supporting the immune system by targeting

the macrophage, a type of white blood cell that coordinates much of the immune

system, to regulate normal immune function.

>

> All immune system regulation research is carried out through Dimethaid AG in

which the Company has a 60% interest. Research and development activities

related to WF10 will be conducted at Nuvo Research GmbH, a wholly owned

subsidiary of Dimethaid AG.

> http://www.nuvoresearch.com/pipeline/iregulation.asp

>

[Guest guest]

Tom where did you hear this? Their site is still up and asking for investors.

>

>

> Hello Healinghope,

>

> WF-10 showed some promise and actually made it through stage 2 clinical

trials. Unfortunately, the final clinical trials have been canceled because it

was not as effective as they were hoping it would be.

>

> Perhaps they will be able to tweak the mix a little and improve their results.

>

> Tom

>

>

> --- In , " healinghope " <mfrreman@>

wrote:

> >

> > Immune Regulation Platform

> > Nuvo's second technology - an immune system regulation platform - is based

on WF10, a solution of OXO-K993 containing stabilized chlorite ions.

> >

> > The immune system provides an essential defence to micro organisms, cancer

and substances it sees as foreign and potentially harmful. The Company's immune

system regulation platform, focuses on supporting the immune system by targeting

the macrophage, a type of white blood cell that coordinates much of the immune

system, to regulate normal immune function.

> >

> > All immune system regulation research is carried out through Dimethaid AG in

which the Company has a 60% interest. Research and development activities

related to WF10 will be conducted at Nuvo Research GmbH, a wholly owned

subsidiary of Dimethaid AG.

> > http://www.nuvoresearch.com/pipeline/iregulation.asp

> >

>

[Guest guest]

WF 10 [immunokine, Macrokine] is a 1 : 10 dilution of tetrachlorodecaoxide

(TCDO) formulated for intravenous injection. It was developed by Oxo Chemie in

Switzerland as an adjunctive therapy to combination antiretroviral and

opportunistic infection prophylaxis regimens in AIDS patients. WF 10

specifically targets macrophages. WF10 potentially modulates disease-related

up-regulation of immune responses both in vitro and in vivo. Thus immune

response is influenced in a way that inappropriate inflammatory reactions are

downregulated.[2]. WF10 is currently being studied in the US, Europe and Asia

for treatment of late-stage HIV disease, as well as recurrent prostate cancer,

late post-radiation cystitis, autoimmune disease and chronic active hepatitis C

disease.[3]

Oxo Chemie has worldwide patent rights to WF 10 and Dimethaid Research has an

exclusive license for marketing and distribution in Canada. WF 10 is approved

for use in Thailand under the name IMMUNOKINE in patients with postradiation

chronic inflammatory disease including cystitis, proctitis and mucositis.[4]

Tetrachlorodecaoxide produces methaemoglobin even if diluted 500 fold, and leads

to additional alterations if added in high concentrations to red cells.[5]

http://en.wikipedia.org/wiki/Tetrachlorodecaoxide

> >

> >

> > Hello Healinghope,

> >

> > WF-10 showed some promise and actually made it through stage 2 clinical

trials. Unfortunately, the final clinical trials have been canceled because it

was not as effective as they were hoping it would be.

> >

> > Perhaps they will be able to tweak the mix a little and improve their

results.

> >

> > Tom

> >

> >

> > --- In , " healinghope " <mfrreman@>

wrote:

> > >

> > > Immune Regulation Platform

> > > Nuvo's second technology - an immune system regulation platform - is based

on WF10, a solution of OXO-K993 containing stabilized chlorite ions.

> > >

> > > The immune system provides an essential defence to micro organisms, cancer

and substances it sees as foreign and potentially harmful. The Company's immune

system regulation platform, focuses on supporting the immune system by targeting

the macrophage, a type of white blood cell that coordinates much of the immune

system, to regulate normal immune function.

> > >

> > > All immune system regulation research is carried out through Dimethaid AG

in which the Company has a 60% interest. Research and development activities

related to WF10 will be conducted at Nuvo Research GmbH, a wholly owned

subsidiary of Dimethaid AG.

> > > http://www.nuvoresearch.com/pipeline/iregulation.asp

> > >

> >

>

[Guest guest]

Mar 15, 2010 ... Nuvo intends to complete the trial in late 2010 or early 2011.

" Positive Phase 2 data from this trial would substantiate WF10 as an ...

http://www.nuvoresearch.com/documents/2010-03-15%20Nuvo%20Phase%202%20WF10%20All\

ergic%20Rhinitis%20Trial.pdf

> >

> >

> > Hello Healinghope,

> >

> > WF-10 showed some promise and actually made it through stage 2 clinical

trials. Unfortunately, the final clinical trials have been canceled because it

was not as effective as they were hoping it would be.

> >

> > Perhaps they will be able to tweak the mix a little and improve their

results.

> >

> > Tom

> >

> >

> > --- In , " healinghope " <mfrreman@>

wrote:

> > >

> > > Immune Regulation Platform

> > > Nuvo's second technology - an immune system regulation platform - is based

on WF10, a solution of OXO-K993 containing stabilized chlorite ions.

> > >

> > > The immune system provides an essential defence to micro organisms, cancer

and substances it sees as foreign and potentially harmful. The Company's immune

system regulation platform, focuses on supporting the immune system by targeting

the macrophage, a type of white blood cell that coordinates much of the immune

system, to regulate normal immune function.

> > >

> > > All immune system regulation research is carried out through Dimethaid AG

in which the Company has a 60% interest. Research and development activities

related to WF10 will be conducted at Nuvo Research GmbH, a wholly owned

subsidiary of Dimethaid AG.

> > > http://www.nuvoresearch.com/pipeline/iregulation.asp

> > >

> >

>

[Guest guest]

For those without pdf. At the first treatment visit, patients who meet the

inclusion and exclusion criteria will be randomized into one of two treatment

groups: WF10, or placebo. Treatment will be administered once daily for five

consecutive days. Patients will be assessed over a three-month period. Nuvo

intends to complete the trial in late 2010 or early 2011.

" Positive Phase 2 data from this trial would substantiate WF10 as an important

therapeutic asset, " said Dr. Henrich Guntermann, President, Europe and

Immunology Group. " We are hopeful that this carefully designed and well

controlled clinical study will provide us with the scientific evidence to

confirm our long-held belief that WF10 can effectively treat patients with

certain autoimmune conditions, such as severe allergic rhinitis.

http://www.medpagetoday.com/PRDir/PressRelease.cfm?id=8040 & sid=80 & cid=1

> > > >

> > > > Immune Regulation Platform

> > > > Nuvo's second technology - an immune system regulation platform - is

based on WF10, a solution of OXO-K993 containing stabilized chlorite ions.

> > > >

> > > > The immune system provides an essential defence to micro organisms,

cancer and substances it sees as foreign and potentially harmful. The Company's

immune system regulation platform, focuses on supporting the immune system by

targeting the macrophage, a type of white blood cell that coordinates much of

the immune system, to regulate normal immune function.

> > > >

> > > > All immune system regulation research is carried out through Dimethaid

AG in which the Company has a 60% interest. Research and development activities

related to WF10 will be conducted at Nuvo Research GmbH, a wholly owned

subsidiary of Dimethaid AG.

> > > > http://www.nuvoresearch.com/pipeline/iregulation.asp

> > > >

> > >

> >

>

[Guest guest]

Hello Healinghope,

That patent was filed in 2005 and issued in 2006, and predates Jim Humbles book.

The concentration they are using is 0.8 PPM available chlorine dioxide.

Tom

--- In , " healinghope " <mfrreman@...>

wrote:

>

> Tom looks like pharmo has wised up and put a patten on chlorine dioxide. Tell

me Tom what is the ppm with this formula and patten? Is this not much stronger

than you have recognized?

> http://www.nuvoresearch.com/pipeline/iregulation.asp

[Guest guest]

Hello Healinghope,

Are you saying that a solution that is a disinfectant, virucide, sanitizer,

fungicide, and algaecide is not a biocide?

Here is a test you can do to demonstrate this to yourself.

Mix up a dose and put it into a container with a lid. Note the appearance, odor

and taste. Place it on the shelf, with the lid on and out of UV light. 24

hours later, note any changes. 48 hours later, once again notice any changes.

If you have test strips, you can monitor the concentration of chlorine dioxide

to see if that changes.

Tom

--- In , " healinghope " <mfrreman@...>

wrote:

>

> Apples and Oranges Tom. Once again this is a biocide process. The question was

drinking at room temperature, sipping throughout the day.

>

[Guest guest]

Hello Healinghope,

That information came up in a discussion with a chemical engineer at OXY Chem

while we were discussing using sodium chlorite for emergency water purification

in the event of a natural disaster.

Tom

> >

> >

> > Hello Healinghope,

> >

> > WF-10 showed some promise and actually made it through stage 2 clinical

trials. Unfortunately, the final clinical trials have been canceled because it

was not as effective as they were hoping it would be.

> >

> > Perhaps they will be able to tweak the mix a little and improve their

results.

> >

> > Tom

> >

[Guest guest]

Hello Healinghope,

I see they have changed the application from autoimmune disease to hay fever.

It will be interesting to see how these trials work out.

Tom

--- In , " healinghope " <mfrreman@...>

wrote:

>

> Mar 15, 2010 ... Nuvo intends to complete the trial in late 2010 or early

2011. " Positive Phase 2 data from this trial would substantiate WF10 as an ...

>

http://www.nuvoresearch.com/documents/2010-03-15%20Nuvo%20Phase%202%20WF10%20All\

ergic%20Rhinitis%20Trial.pdf

>

[Guest guest]

Actually, it looks like they had reasonable success with their initial trial.

Their original tests were done looking at AIDs.

http://www.ncbi.nlm.nih.gov/pubmed/9717676?dopt=Abstract

This seems pretty promising to me...

Tom

>

>

> Hello Healinghope,

>

> I see they have changed the application from autoimmune disease to hay fever.

It will be interesting to see how these trials work out.

>

> Tom

>

>

> --- In , " healinghope " <mfrreman@>

wrote:

> >

> > Mar 15, 2010 ... Nuvo intends to complete the trial in late 2010 or early

2011. " Positive Phase 2 data from this trial would substantiate WF10 as an ...

> >

http://www.nuvoresearch.com/documents/2010-03-15%20Nuvo%20Phase%202%20WF10%20All\

ergic%20Rhinitis%20Trial.pdf

> >

>

[Guest guest]

Hello Healinghope,

That is wonderful news for Vertex, but I believe Nuvo is the company that is

researching WF-10. Are those two companies related?

Tom

--- In , " healinghope " <mfrreman@...>

wrote:

>

> Tom this is being delayed because of the FDA, thats all. Aids hepatitis all

still in the phase 3 study.

> FDA Wants Additional 48-Week Trial Vertex Starts 24-Week Telaprevir Phase III

Study in HCV Patients

>

http://www.allbusiness.com/medicine-health/diseases-disorders-liver-disease-hepa\

titis/12861689-1.html

>

[Guest guest]

Nuvo is the researcher and Vertex Pharmaceutical.

>

>

> Hello Healinghope,

>

> That is wonderful news for Vertex, but I believe Nuvo is the company that is

researching WF-10. Are those two companies related?

>

> Tom

>

>

> --- In , " healinghope " <mfrreman@>

wrote:

> >

> > Tom this is being delayed because of the FDA, thats all. Aids hepatitis all

still in the phase 3 study.

> > FDA Wants Additional 48-Week Trial Vertex Starts 24-Week Telaprevir Phase

III Study in HCV Patients

> >

http://www.allbusiness.com/medicine-health/diseases-disorders-liver-disease-hepa\

titis/12861689-1.html

> >

>

[Guest guest]

Tom I am surprised the info came from oxo chem looks like they are apart of the

phase 3 study.

http://www.thefreelibrary.com/OXO+CHEMIE+AG+INITIATES+MACROKINE+PHASE+2+CLINICAL\

+TRIALS-a063577615

OXO CHEMIE AG INITIATES MACROKINE PHASE 2 CLINICAL TRIALS.

The company's lead drug, WF10, is approved for use in Thailand under the name

IMMUNOKINE, in patients with postradiation chronic inflammatory diseases

including cystitis, proctitis and mucositis. A Phase 3 clinical trial of WF10 is

underway in the US and Canada in patients with advanced HIV disease; patient

enrollment is nearing completion. The company also has ongoing trials in cancer

and hepatitis C.

> > >

> > >

> > > Hello Healinghope,

> > >

> > > WF-10 showed some promise and actually made it through stage 2 clinical

trials. Unfortunately, the final clinical trials have been canceled because it

was not as effective as they were hoping it would be.

> > >

> > > Perhaps they will be able to tweak the mix a little and improve their

results.

> > >

> > > Tom

> > >

>

[Guest guest]

Morgellon has many symptoms from actual insects in bedded in the skin to just

the feeling of insects. There is a correlation with lyme disease as well. The

jury is still out in my opinion on what morgellon really is. Here is a link if

interested. The CDC has been studying this for over 2 years with no outcome:(

http://www.morgellons-research.org/morgellons/morgellons-intro.htm

>

> > I have a question. I have little brown beetle resembling bugs living in a

lesion. I didn't know what was causing the lesion. But after soaking for three

hours in MMS1 one of the little bugs came out of the lesion and appeared to be

dead. I saved it in a baggy for the doctor. After two hours it revived and

lived for days and days crawling around speedily and trying to burrow in. Its

behavior so exactly mimicked the pain I feel in the lesion that I know for sure

that the lesion is a nest for these bugs.

> >

> > Since then I have applied and sprayed with MMS continually with no success,

but when I pack it in clay I will get another bug out. MMS does NOT kill these

bugs!!! It really doesn't. What is your feedback on this please?

> >

> > Glenn

> >

> >

> >

> >

>

[Guest guest]

silverfox

thank you . i want to make this[20 drops] the next time i get sick and drink cups of it throughout the day? have you heard of anyone doing this before?

kevin

From: silverfox_science <poast@...> Sent: Sun, August 29, 2010 8:40:38 AMSubject: [ ] Re: Killing Capacity of MMS

Hello ,Chlorous acid (activated MMS) is unstable because the chlorine dioxide is very energetic and tries to escape from the solution. Chlorine dioxide is also very reactive to heat and UV light.If you put a solution of chlorous acid into a cake pan and set it outside in the sun, the effectiveness of the solution will only last for 30 - 60 minutes.On the other hand, if you put the solution into a water bottle and put the lid on and store it away from UV light and excess heat, it will still be effective after 6 - 8 weeks, depending upon the concentration.The answer to your question is that it will last anywhere from a few minutes to several weeks, depending upon the dilution and storage conditions.20 drops of MMS in 2 liters of water will give you a concentration of about 80 PPM available chlorine dioxide with about 8 PPM of that as free chlorine dioxide. If you keep the bottle out of UV light there

should be no problem keeping that solution for a day.Tom>> silverfox_science or anyone who has the wisdom and understanding to help me > understand these questions?> > how long does an activated 20 drops of mms1 last for?> > and if i'm sick with a strong cold or flu, will the 20 drop activated mms1 be > affective still in a half gallon of filtered water all day long?>

[Guest guest]

Hello ,

In our group many people have done that same thing and tried various

concentrations. In some cases it helps almost immediately, in other cases it

doesn't seem to help at all.

We have actually moved on to explore the idea of using a 10 - 20 PPM available

chlorine dioxide solution with no free chlorine dioxide applied through the

nose. 0.2 ml is injected in each nostril every couple of hours. This idea is

borrowed from Zycam.

Unfortunately, for the experiment, we tend to be healthy so we have very little

results to go from.

The major issue with this idea is that the sinus area has a flora associated

with it, and this method of treatment may kill off that flora. We are having

some heated debates with those that understand how this area of the body works.

Any form of treatment seems to be more effective if you catch the symptoms early

on.

Tom

>

> silverfox

>

> thank you . i want to make this[20 drops] the next time i get sick and drink

> cups of it throughout the day? have you heard of anyone doing this before?

>

> kevin

>

>

[Guest guest]

,

I have used the 20 drops in a bottle and sipped it every hour or so. This is

for me one of the best ways to get over a cold. However, I activated the 20

drops of MMS with a hundred drops of citric acid for three minutes, then filled

the bottle up with distilled water.

Tim

> >

> > silverfox_science or anyone who has the wisdom and understanding to help me

> > understand these questions?

> >

> > how long does an activated 20 drops of mms1 last for?

> >

> > and if i'm sick with a strong cold or flu, will the 20 drop activated

mms1 be

> >

> > affective still in a half gallon of filtered water all day long?

> >

>

[Guest guest]

tim, thank you very very much for your feedback

when YAHUAH put this thought on my mind, i new it was a good idea. it just seemed like the thing to do! if you have any other helpful experiences please share them with me whenever? blessings to you friend.

kevin

From: chasson321 <chasson321@...> Sent: Mon, August 30, 2010 9:09:58 PMSubject: [ ] Re: Killing Capacity of MMS

,I have used the 20 drops in a bottle and sipped it every hour or so. This is for me one of the best ways to get over a cold. However, I activated the 20 drops of MMS with a hundred drops of citric acid for three minutes, then filled the bottle up with distilled water.Tim> >> > silverfox_science or anyone who has the wisdom and understanding to help me > > understand these

questions?> > > > how long does an activated 20 drops of mms1 last for?> > > > and if i'm sick with a strong cold or flu, will the 20 drop activated mms1 be > >> > affective still in a half gallon of filtered water all day long?> >>

[Guest guest]

,

That protocol is from Jim Humbles web site.

Tim

Hallelu YAH

> > >

> > > silverfox_science or anyone who has the wisdom and understanding to help

me

> > > understand these questions?

> > >

> > > how long does an activated 20 drops of mms1 last for?

> > >

> > > and if i'm sick with a strong cold or flu, will the 20

drop activated

> >mms1 be

> >

> > >

> > > affective still in a half gallon of filtered water all day long?

> > >

> >

>